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Fig. 1. Sagittal magnetic resonance image showing diffuse bone 
metastases with pathological fractures, metastases in L5 with 
penetration of the rear edge and epidural fat tissue, and com-
pression of the S1 nerve. 
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Diffuse Cutaneous Melanosis Associated with Malignant 
Melanoma
Joanna Mangana, Lea Felderer, Phil Cheng, Lars E. French, Reinhard Dummer, Karin Schad
Department of Dermatology, University Hospital Zurich, Zurich, Switzerland
Dear Editor:
Diffuse cutaneous melanosis (DCM) is a rare condition af-
fecting a minority of advanced melanoma patients. It is of-
ten described in the setting of metastatic disease of the liv-
er and was first defined by the German pathologist Wagner1, 
who reported on a patient with melanoma arising from a 
congenital nevus with subsequent gray skin coloration. 
We report on an otherwise healthy 45-year-old Caucasian 
woman with a 3-mm-thick nodular melanoma (pT3a) on 
the right flank. At the time of the first diagnosis (2011), 
there were no clinical/radiological signs of metastatic disease. 
After the positive sentinel-lymph-node biopsy (sn1/3), she 
underwent a complete lymphadenectomy. Two years later 
and upon negative clinical and radiological follow-up, she 
complained of intense lower-back pain radiating down to 
the left leg. Magnetic resonance imaging of the spine 
showed diffuse bone metastases with pathological frac-
tures and multiple metastases in L5 with penetration of the 
rear edge and epidural fat tissue with compression of the 
S1 nerve. A computed tomography-controlled percuta-
neous aspiration biopsy was performed for routine molec-
ular diagnostics. The melanoma tissue showed the pres-
ence of wild-type BRAF. The patient was treated with 
combination chemotherapy (vindesine/cisplatin) and symp-
tomatic palliative radiotherapy of the spinal cord with five 
4-Gy sessions, amounting to a total dose of 20 Gy. After 
two cycles of chemotherapy, she was hospitalized be-
cause of pain exacerbation. Subsequent imaging studies 
showed disease progression with new liver metastasis and 
progressive spinal metastasis (M1c) (Fig. 1). High levels of 
lactate dehydrogenase (1,264 U/L) and S-100 (18.3 μg/L) 
were detected. Furthermore, she developed diffuse gray 
hyperpigmentation affecting the entire skin and sclera cor-
responding to DCM (Fig. 2). No pigment changes of the 
hair were noted. The patient was treated symptomatically 
and was transferred to a palliative care unit. Four months 
after the onset of DCM, she died.
The clinical presentation of DCM consists of diffuse 
blue-grayish pigmentation of the skin and sclera, with a 
descending cephalo-caudal progression2. Additional clin-
ical features include melanuria, hair pigment changes, and 
darkening of the serum or peritoneal fluids. Histologically, 
in most of the published cases, the presence of dermal 
pigment, deposition of melanin in histiocytes, and free mel-
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Fig. 2. Brown-gray hyperpigmen-
tation of sun-exposed skin areas 
because of disease progression. (A) 
Before onset of diffuse cutaneous 
melanosis (DCM). (B) After onset of 
DCM.
anin in dermal connective tissue are reported3. DCM has a 
poor outcome with a mean time to death of approximately 
4∼5 months after disease onset4. 
The pathogenesis of DCM is yet unclear. One current pro-
posed theory is that elevated melanocytic growth factors 
such as α-melanocyte-stimulating hormone, endothelin-1, 
and hepatocyte growth factor activate the melanogenesis, 
proliferation, and motility of normal and malignant mela-
nocytes5. Nevertheless, this hypothesis is contradictory to 
the fact that no alteration in melanocyte numbers or kera-
tinocyte pigmentation was observed in most cases of 
DCM. 
Oncologists and dermato-oncologists should be familiar 
with DCM and its underlying poor prognosis. Taking into 
account the anticipated survival of these patients, an inter-
disciplinary palliative care treatment aimed at providing 
good individualized symptom control and relief in all 
areas of the patient’s life should be offered in experienced 
centers.
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